We wish a warm welcome to the four new patient representatives of Euro-NMD:
In total, 33 patient representatives from 23 patient organisations and 11 countries form part of our network. All are interested to take part in the activities of one or more Euro-NMD working groups. An overview of patient participation in the different working groups is available here.
Among them, the Patient Advisory Board (PAB) is comprised of nine members, and chaired by François Lamy (AFM-Téléthon). The PAB aims to ensure true and equitable representation of the voice of patients within Euro-NMD, including by coordinating the participation of all 33 patient representatives in the network, and creating a bridge between the ERN and the rare neuromuscular patient community.
